These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 7563175)

  • 21. Chemotherapy studies in an animal tumor spectrum. IV. Effects of additional selected chemicals on the growth of tumors.
    Tarnowski GS; Schmid FA; Cappuccino JG; Stock CC
    Cancer Chemother Rep 2; 1968 Nov; 1(2):403-534. PubMed ID: 5732305
    [No Abstract]   [Full Text] [Related]  

  • 22. [On some biological effects of the cytostatic agent verrucarin A].
    Rüsch ME; Stähelin H
    Arzneimittelforschung; 1965 Aug; 15(8):893-7. PubMed ID: 4955716
    [No Abstract]   [Full Text] [Related]  

  • 23. alpha-Difluoromethylornithine, a polyamine inhibitor: its potential role in controlling hair growth and in cancer treatment and chemo-prevention.
    Smith KJ; Skelton H
    Int J Dermatol; 2006 Apr; 45(4):337-44. PubMed ID: 16650154
    [No Abstract]   [Full Text] [Related]  

  • 24. Angiogenesis. A boost for tumor starvation.
    Marx J
    Science; 2003 Jul; 301(5632):452-4. PubMed ID: 12881543
    [No Abstract]   [Full Text] [Related]  

  • 25. [Enhancement of antitumor effect of chemotherapeutic agents viewed from tumor-host relationship].
    Saito T
    Saishin Igaku; 1970 May; 25(5):1080-8. PubMed ID: 4912178
    [No Abstract]   [Full Text] [Related]  

  • 26. [The effect of cycloferon administration on the growth of transplantable tumors in rats and mice].
    Zabezhinskiĭ MA; Popovich IG; Shtylik AV; Kovalenko AL; Anisimov VN
    Vopr Onkol; 1998; 44(4):427-31. PubMed ID: 9807206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antineoplastic effect of 1,4-benzoquinone guanylhydrazone thiosemicarbazone in experimental tumor models].
    Fichtner I; Arnold W
    Pharmazie; 1983 Feb; 38(2):130-1. PubMed ID: 6856663
    [No Abstract]   [Full Text] [Related]  

  • 28. [An experimental study of the antitumor properties of olipifat].
    Filov VA; Reztsova VV; Kil'maeva NE; Petukhov DV; Pinchuk BT
    Vopr Onkol; 2000; 46(3):332-6. PubMed ID: 10976281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The possibility of local cytostatic therapy].
    Grundmann E
    HNO; 1966 May; 14(5):129-33. PubMed ID: 5987279
    [No Abstract]   [Full Text] [Related]  

  • 30. [The biochemical mechanism of the antiblastic action of cytostatic drugs].
    Zimel H
    Stud Cercet Endocrinol; 1967; 18(4):369-71. PubMed ID: 6082522
    [No Abstract]   [Full Text] [Related]  

  • 31. From trench warfare to war on cancer. The development of chemotherapy for malignant disease.
    Weisse AB
    Hosp Pract (Off Ed); 1992 Mar; 27(3A):141-3, 147-8. PubMed ID: 1548325
    [No Abstract]   [Full Text] [Related]  

  • 32. Matrix metalloproteinase inhibitors as anticancer agents.
    Konstantinopoulos PA; Karamouzis MV; Papatsoris AG; Papavassiliou AG
    Int J Biochem Cell Biol; 2008; 40(6-7):1156-68. PubMed ID: 18164645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Alkyl nitrosoureidodioxans and alkyl nitrosoureidopropane diols -- new groups of antitumor compounds].
    Kon'kov SA; Stukov AN; Reztsova VV; Krylova IM; Ivin BA; VA Filov
    Vopr Onkol; 1998; 44(1):97-9. PubMed ID: 9578740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assays for in vitro and in vivo synergy.
    Teicher BA
    Methods Mol Med; 2003; 85():297-321. PubMed ID: 12710216
    [No Abstract]   [Full Text] [Related]  

  • 35. [Temperature dependence of cytostatic drug effect. Metabolic milieu and tumor oxygenation with hyperthermia].
    Wiedemann GJ
    Fortschr Med; 1995 Apr; 113(11):166. PubMed ID: 7768480
    [No Abstract]   [Full Text] [Related]  

  • 36. Criteria for the evaluation of cytostatic chemotherapy.
    Dold U
    Int J Clin Pharmacol Biopharm; 1978 Feb; 16(2):68-71. PubMed ID: 631973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Factors affecting the effect of anticancer drugs. 2. Relation to the host resistance to the tumor].
    Ishikawa Y; Fukushima M; Horimai T; Sato T; Machida S
    Igaku To Seibutsugaku; 1967 Feb; 74(2):112-7. PubMed ID: 5624325
    [No Abstract]   [Full Text] [Related]  

  • 38. Screening data from the Cancer Chemotherapy National Service Centescreening laboratories. 34. Plant extracts.
    Abbott BJ; Leiter J; Hartwell JL; Caldwell ME; Beal JL; Perdue RE; Schepartz SA
    Cancer Res; 1966 Jul; 26(7 Pt 2):761-935. PubMed ID: 5944776
    [No Abstract]   [Full Text] [Related]  

  • 39. Reporting cytotoxicity and antitumor activity.
    Farnsworth NR
    J Pharm Sci; 1977 Dec; 66(12):IV. PubMed ID: 925925
    [No Abstract]   [Full Text] [Related]  

  • 40. Heparin and cancer.
    Zacharski LR; Ornstein DL
    Thromb Haemost; 1998 Jul; 80(1):10-23. PubMed ID: 9684778
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.